SPY306.41+0.86 0.28%
DIA256.67+1.40 0.55%
IXIC9,561.19+9.14 0.10%

Kindred Biosciences Q1 EPS $(0.580) Misses $(0.430) Estimate, Sales $603.000K Miss $1.590M Estimate

Kindred Biosciences (NASDAQ:KIN) reported quarterly losses of $(0.580) per share which missed the analyst consensus estimate of $(0.430) by 34.88 percent. This is a 38.1 percent decrease over losses of $(0.420) per share

Benzinga · 05/07/2020 20:21

Kindred Biosciences (NASDAQ:KIN) reported quarterly losses of $(0.580) per share which missed the analyst consensus estimate of $(0.430) by 34.88 percent. This is a 38.1 percent decrease over losses of $(0.420) per share from the same period last year. The company reported quarterly sales of $603.000 thousand which missed the analyst consensus estimate of $1.590 million by 62.08 percent. This is a 17.09 percent increase over sales of $515.000 thousand the same period last year.